Can Clorox Deliver a Q2 Earnings Beat Despite Cost Headwinds?

Core Viewpoint - Clorox Company (CLX) is expected to report declines in both revenue and earnings for the second quarter of fiscal 2026, with significant cost pressures impacting profitability [1][4][8]. Financial Performance Expectations - The Zacks Consensus Estimate for fiscal second-quarter revenues is $1.63 billion, reflecting a 3.3% decline from the previous year [2]. - The consensus estimate for earnings per share (EPS) has decreased by 2.1% over the past 30 days to $1.43, indicating a 7.7% decline year-over-year [2]. - Clorox has a trailing four-quarter earnings surprise of 10.2%, including a 9% surprise in the last reported quarter [2]. Earnings Prediction Model - The current model indicates that Clorox is unlikely to achieve an earnings beat this quarter, with an Earnings ESP of -1.04% and a Zacks Rank of 3 (Hold) [3]. Cost Pressures and Profitability - Clorox is facing elevated cost pressures from manufacturing, logistics, and promotional spending, which are expected to negatively impact profitability throughout fiscal 2026 [4][6]. - Operating income is projected to decline by 8.4% year-over-year, with a contraction of 90 basis points in operating margin [5]. Market and Competitive Environment - The company anticipates a challenging external environment in 2026, with consumers remaining value-conscious and overall category consumption expected to be sluggish [7]. - Competitive intensity is expected to remain high, alongside tariff-related uncertainties [7]. Strategic Initiatives - Clorox is focusing on brand strength, disciplined cost management, and the execution of its IGNITE strategy to support recovery [10]. - The company is nearing completion of a multi-year digital transformation, including a new ERP system aimed at enhancing operational efficiency [12]. - A holistic margin-management program is in place to optimize costs and productivity, which is expected to support growth initiatives despite near-term challenges [11]. Valuation Metrics - Clorox stock is currently trading at a forward 12-month price-to-earnings ratio of 17.13X, which is below the industry average of 18.15X [14]. - Over the past three months, Clorox has seen a decline of 2.5%, underperforming the industry’s decline of 0.2% [15].